ReviewBiomedicines2024

Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors as a New Treatment Option for Anemia in Chronic Kidney Disease.

Piotr BartnickiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.